↓ Skip to main content

Activation of Akt, mTOR, and the estrogen receptor as a signature to predict tamoxifen treatment benefit

Overview of attention for article published in Breast Cancer Research and Treatment, December 2012
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#9 of 4,676)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news
56 news outlets
patent
4 patents

Citations

dimensions_citation
81 Dimensions

Readers on

mendeley
59 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Activation of Akt, mTOR, and the estrogen receptor as a signature to predict tamoxifen treatment benefit
Published in
Breast Cancer Research and Treatment, December 2012
DOI 10.1007/s10549-012-2376-y
Pubmed ID
Authors

Josefine Bostner, Elin Karlsson, Muneeswaran J. Pandiyan, Hanna Westman, Lambert Skoog, Tommy Fornander, Bo Nordenskjöld, Olle Stål

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 59 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Netherlands 1 2%
Unknown 58 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 16 27%
Student > Ph. D. Student 10 17%
Student > Postgraduate 5 8%
Student > Bachelor 4 7%
Student > Master 4 7%
Other 8 14%
Unknown 12 20%
Readers by discipline Count As %
Medicine and Dentistry 14 24%
Biochemistry, Genetics and Molecular Biology 12 20%
Agricultural and Biological Sciences 7 12%
Chemistry 3 5%
Nursing and Health Professions 2 3%
Other 8 14%
Unknown 13 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 441. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 April 2024.
All research outputs
#52,449
of 22,988,380 outputs
Outputs from Breast Cancer Research and Treatment
#9
of 4,676 outputs
Outputs of similar age
#280
of 280,447 outputs
Outputs of similar age from Breast Cancer Research and Treatment
#1
of 62 outputs
Altmetric has tracked 22,988,380 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,676 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.2. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 280,447 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 62 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.